Your browser doesn't support javascript.
WHO international non-proprietary names: the need to distinguish COVID-19 vaccines.
Loizides, Ursula; Adisa, Akinola; de la Rica Manjavacas, Ana López; Robertson, James S; Balocco, Raffaella.
  • Loizides U; International Nonproprietary Names Programme and Classification of Medical Products, WHO, Geneva 1211, Switzerland.
  • Adisa A; Therapeutic Goods Administration, Australian Government Department of Health, Canberra, ACT, Australia.
  • de la Rica Manjavacas AL; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
  • Robertson JS; St Albans, UK.
  • Balocco R; International Nonproprietary Names Programme and Classification of Medical Products, WHO, Geneva 1211, Switzerland. Electronic address: baloccor@who.int.
Lancet ; 397(10274): 577-578, 2021 02 13.
Article in English | MEDLINE | ID: covidwho-1062662

Full text: Available Collection: International databases Database: MEDLINE Main subject: World Health Organization / COVID-19 Vaccines / Terminology as Topic Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)00099-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: World Health Organization / COVID-19 Vaccines / Terminology as Topic Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)00099-4